10X GENOMICS INC's ticker is TXG and the CUSIP is 88025U109. A total of 250 filers reported holding 10X GENOMICS INC in Q2 2022. The put-call ratio across all filers is 0.59 and the average weighting 1.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $70,886,929 | -28.1% | 1,718,471 | -2.7% | 0.85% | -18.4% |
Q2 2023 | $98,575,346 | -10.1% | 1,765,634 | -12.6% | 1.04% | -17.9% |
Q1 2023 | $109,663,204 | +38.2% | 2,021,069 | -7.2% | 1.26% | +10.6% |
Q4 2022 | $79,365,883 | +29.8% | 2,177,988 | -1.3% | 1.14% | +46.4% |
Q3 2022 | $61,141,000 | +8.1% | 2,207,258 | +56.1% | 0.78% | +11.9% |
Q2 2022 | $56,554,000 | -48.1% | 1,413,839 | -1.3% | 0.70% | -12.8% |
Q1 2022 | $108,915,000 | -34.5% | 1,431,773 | +14.7% | 0.80% | -8.5% |
Q4 2021 | $166,291,000 | -13.3% | 1,247,960 | -6.4% | 0.87% | +6.2% |
Q3 2021 | $191,750,000 | -36.0% | 1,333,544 | -13.5% | 0.82% | -29.8% |
Q2 2021 | $299,376,000 | +58.6% | 1,541,588 | +47.8% | 1.17% | +26.7% |
Q1 2021 | $188,767,000 | +1026.2% | 1,042,913 | +781.0% | 0.92% | +873.7% |
Q4 2020 | $16,762,000 | +37.9% | 118,379 | +15.8% | 0.10% | -12.0% |
Q3 2020 | $12,158,000 | -31.5% | 102,268 | -50.4% | 0.11% | -53.6% |
Q2 2020 | $17,755,000 | – | 206,213 | – | 0.23% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Venrock Management VI, LLC | 962,309 | $188,439,000 | 95.08% |
Foresite Capital Management II, LLC | 1,753,528 | $343,376,000 | 92.37% |
Foresite Capital Management I, LLC | 750,000 | $146,865,000 | 88.53% |
12 West Capital Management LP | 1,922,000 | $376,366,000 | 15.78% |
Financial Consulate Inc. | 141,258 | $27,661,000 | 9.97% |
FINANCIAL CONSULATE, INC | 141,258 | $27,661,000 | 9.97% |
Meritech Capital Associates V L.L.C. | 1,793,871 | $351,276,000 | 7.51% |
Andar Capital Management HK Ltd | 51,000 | $9,987,000 | 6.81% |
JS Capital Management LLC | 540,589 | $105,858,000 | 5.12% |
Renaissance Capital LLC | 97,281 | $19,050,000 | 3.01% |